SRJ Technologies Group Notifies Cessation of 9.75 Million Options Expiring 12 November 2026

Sonal Goyal

13 November 2026 12:11 PM AEDT

SRJ Technologies Group Notifies Cessation of 9.75 Million Options Expiring 12 November 2026

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

SRJ Technologies Group PLC (ASX:SRJ) has notified the market of the cessation of 9,750,000 unquoted options following their expiry on 12 November 2026 without exercise or conversion, according to an Appendix 3H filing lodged on 13 November 2026.

Key Points

9,750,000 options under the SRJAO class, with an exercise price of $0.115, ceased on 12 November 2026 due to expiry without exercise or conversion.
No consideration was paid by the entity for the cessation of the securities.
Following the cessation, SRJ Technologies has 1,723,218,382 CHESS Depositary Interests quoted on ASX.
The SRJAO class now shows zero securities on issue following the expiry.

Details of Ceased Securities

The ceased securities were classified under ASX security code SRJAO, described as options expiring 12 November 2026 with an exercise price of $0.115. The filing states the reason for cessation was the expiry of the option or other convertible security without exercise or conversion. The date of cessation is recorded as 12 November 2026. The entity confirmed it is not paying any consideration for the cessation and provided no additional information regarding the cessation beyond the standard disclosure requirements.

Issued Capital Following the Cessation

Following the cessation, SRJ Technologies disclosed its updated issued capital. Quoted securities comprise 1,723,218,382 CHESS Depositary Interests listed under the SRJ security code. Unquoted equity securities remaining on issue include several option classes: SRJAW with 60,999,000 options, SRJAR with 12,300,000, SRJAS with 7,000,000, SRJAT with 9,000,000, SRJAU with 12,000,000, SRJAV with 41,000,000, SRJAX with 50,000,000, SRJAM with 7,000,000, and SRJAA ordinary fully paid shares totalling 17,782,618.

Remaining Unquoted Option Classes on Issue

Among the remaining unquoted option classes disclosed, expiry dates and exercise prices vary across the different series. SRJAR, SRJAS, SRJAT, SRJAU, and SRJAV options are all set to expire on 19 December 2028, with exercise prices of nil, $0.02, $0.03, $0.04, and $0.01 respectively. SRJAX options expire on 15 July 2029 at an exercise price of $0.0135, while SRJAM options expire on 19 August 2027 at an exercise price of $0.066. The SRJW class covers options expiring on various dates at various prices, with 60,999,000 securities on issue.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.